ER−/ER+ breast cancer cell lines exhibited different resistance to paclitaxel through pulse selection
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ER−/ER+ breast cancer cell lines exhibited different resistance to paclitaxel through pulse selection
Authors
Keywords
-
Journal
MEDICAL ONCOLOGY
Volume 29, Issue 2, Pages 495-502
Publisher
Springer Nature
Online
2011-03-12
DOI
10.1007/s12032-011-9889-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proinflammatory Cytokines Enhance Estrogen-dependent Expression of the Multidrug Transporter GeneABCG2through Estrogen Receptor and NFκB Cooperativity at Adjacent Response Elements
- (2010) Madhumita Pradhan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Proteomic Identification of Paclitaxel-Resistance Associated hnRNP A2 and GDI 2 Proteins in Human Ovarian Cancer Cells
- (2010) Dong Hyeon Lee et al. JOURNAL OF PROTEOME RESEARCH
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Directed Therapy of Subtypes of Triple-Negative Breast Cancer
- (2010) L. A. Carey ONCOLOGIST
- Chemotherapy for breast cancer (Review)
- (2010) Hassan ONCOLOGY REPORTS
- Cell Cycle and Anti-Estrogen Effects Synergize to Regulate Cell Proliferation and ER Target Gene Expression
- (2010) Mathieu Dalvai et al. PLoS One
- Cancer Cells Acquire Mitotic Drug Resistance Properties Through Beta I-Tubulin Mutations and Alterations in the Expression of Beta-Tubulin Isotypes
- (2010) Chun Hei Antonio Cheung et al. PLoS One
- What is the role of chemotherapy in estrogen receptor-positive, advanced breast cancer?
- (2009) C. H. Barrios et al. ANNALS OF ONCOLOGY
- Triple-negative breast cancer--current status and future directions
- (2009) O. Gluz et al. ANNALS OF ONCOLOGY
- Safety and pharmacokinetics of paclitaxel and the oral mTOR inhibitor everolimus in advanced solid tumours
- (2009) M Campone et al. BRITISH JOURNAL OF CANCER
- Contemplating chemosensitivity of basal-like breast cancer based on BRCA1 dysfunction
- (2009) Tomohiko Ohta et al. Breast Cancer
- CYP1B1 expression is induced by docetaxel: effect on cell viability and drug resistance
- (2008) V G Martinez et al. BRITISH JOURNAL OF CANCER
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- Resistance to therapy caused by intragenic deletion in BRCA2
- (2008) Stacey L. Edwards et al. NATURE
- Is triple negative a prognostic factor in breast cancer?
- (2008) Reiki Nishimura et al. Breast Cancer
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search